MNOV Latest Press Releases

-- March 16, 2026 --

MediciNova to Participate at the 38th Annual ROTH Conference Globe Newswire 7:00 AM

-- January 29, 2026 --

MediciNova Announces 100 Patients Enrolled in SEANOBI Study Expanded-Access-Program (EAP) Evaluating MN-166 (ibudilast) in ALS patients Globe Newswire 6:00 PM

-- January 6, 2026 --

2026 New Year's Greetings from the CEO Globe Newswire 9:00 AM

-- December 18, 2025 --

MediciNova Announces Completion of Patient Enrollment Evaluating MN-166 (ibudilast) in the Prevention of Chemotherapy-induced Peripheral Neuropathy Globe Newswire 6:00 AM

-- December 8, 2025 --

MediciNova Announces Update and Basic Characteristic Randomized Patients' of Phase 2/3 Clinical Trial of MN-166 (Ibudilast) in ALS (COMBAT-ALS Clinical Trial) Presented at the 36th International Symposium on ALS/MND Globe Newswire 6:00 AM

-- December 1, 2025 --

Message from the CEO to MediciNova Shareholders Globe Newswire 6:00 PM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software